Insider filing · BMRN
Charles Greg Guyer
EVP, Chief Technical Officer
profile →
BioMarin Pharmaceutical Inc.
BMRN · Healthcare · 8 filings in 24 months
ticker →
Charles Greg Guyer sold $350K of BioMarin Pharmaceutical (BMRN)
Executed Nov 12 2024, disclosed Nov 14 2024, 2 days later.
Value, as filed
$350K
5,278 sh × $66.37
Executed
Nov 12 2024
the trade date, as filed
Disclosed
Nov 14 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CGCharles Greg Guyer (EVP, Chief Technical Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BioMarin Pharmaceutical Inc. (BMRN). The largest single filing was $997K of BMRN (16,486 sh × $60.46, as filed), executed Mar 11.
The name
BMRNHealthcare · BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening r…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Charles Greg Guyer in BMRN
BMRNSALE
BioMarin Pharmaceutical Inc.
$997K16,486 sh × $60.46
Exec Mar 11
Filed Mar 12 · 5:30 PM ET BMRNSALE BioMarin Pharmaceutical Inc. $501K
7,034 sh × $71.28
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET